SafeBeat Rx

Remote Patient Monitoring, Event Monitoring, Mobile Cardiac Telemetry, and Health Tracking Services

Our unique devices and algorithms are designed to help clinicians quickly see the full picture without being buried in notifications. All software is designed for physicians, by physicians. 

 

With patient and clinician experience at the top of our mind, we aim for top notch compliance and impact in remote care.

Advanced Artificial Intelligence

Our proprietary machine learning algorithms power our solutions, and we are making our software available to power your products as well.


From ECG interpretation to treatment management, our world-class AI delivers efficiency and automated insights.

Testimonials and Support:

Testimonials and Support:

Heart Rhythm Society plays a key role in supporting new technologies like yours, which respond to the needs of both patients and healthcare systems and help advance our specialty.

Christine Albert, MD, MPH

Past President, Heart Rhythm Society
Founding Chair of the Department of Cardiology at Cedars-Sinai

Your product has the real potential to upend the current in-patient workflow of patients…and to dramatically improve the care of patients who currently require in-patient monitoring for drug initiation, and may thus improve patient care, workflow and cost effectiveness.

Sanjiv M. Narayan, MD, PhD

Professor of medicine
Co-Director, Arrhythmia Center
Stanford University Medical Center

I am excited by the potential of SafeBeat Rx technology to both reduce the cost of care and also expand access to guideline-directed therapy. By transitioning [low acuity] out of the hospital, we can preserve inpatient beds for patients who truly require acute inpatient care.

Joshua Adler, MD

Chief Clinical Officer
Vice Dean for Clinical Affairs, UCSF School of Medicine
Professor of Clinical Medicine

In addition to being a huge satisfier for patients, this technology has the potential to enable hospitals to optimize patient throughput. Better utilization of a limited bed platform allows hospitals to care for an expanded population of high acuity patients who cannot safely receive care outside of the inpatient setting.

Katherine Henderson, M.D

Vice President & Chief Medical Officer
Barnes Jewish Hospital

I expect the technology developed…to make an immediate and widespread impact on the treatment of atrial fibrillation patients in the VA system and in the broader community, by improving access and reducing health disparities.

Cara N Pellegrini, MD

Director, Cardiac Electrophysiology
San Francisco VA Medical Center
Assoc Director, Cardiology Fellowship University of California San Francisco
Assoc Professor of Clinical Medicine

In assessing the digital health landscape today, the capability of your technology to go beyond diagnostics to bring mortality reducing medications to larger populations will both reduce healthcare costs and improve cardiovascular outcomes.

Melvin Scheinman, MD

Professor of Medicine Walter H. Shorenstein Endowed Chair in Cardiology
"Founding Father of Cardiac Electrophysiology"

The alternative you offer to current standard of care is not just incrementally better but radically improved, and your [team’s] backgrounds make you uniquely qualified to solve the pain points facing doctors and patients.

Jared Friedman

Partner at Y Combinator

SafeBeat Rx remote monitoring analysis platform will enable healthcare providers to support all AFib patients, and save hundreds of thousands of lives.

Seth Bannon

Founding Partner, Fifty Years VC

SafeBeat Rx is part of a digital health revolution that is leveraging machine learning software technology and biosensors to provide hospital-level care to patients in their home environments… The potential impact of SafeBeat Rx is vast, including increased patient access, reduction of health disparities, cost savings to the healthcare system, and expedited pharmaceutical trials.

Lu Zhang

Founder & Managing Partner
Fusion Fund, VC

Founders

Rachita Navara, MD.

Cardiologist and Bioengineer

Founder and CEO

Dr. Navara is a bioengineer and cardiologist specializing in heart rhythm disorders. She has been internationally recognized for her atrial fibrillation research, and she has led numerous award-winning medical innovation teams within academia (Stanford, UCSF, Wash U, MIT, Olin College of Engineering, UT Southwestern) and industry (Boston Scientific, Preserve, Harvard Brigham and Women’s Hospital). She is an appointed member of the National ACC Heart Rhythm Leadership Council and is HRS delegate to the AMA, directly shaping arrhythmia treatment guidelines.

Kunj G. Patel, MD MSc.

Pain Physician and Mathematician

Founder, President, and CTO

Dr. Patel is a physical medicine and interventional pain physician from Harvard, Emory, Wash U, and NJIT with masters-level expertise in applied mathematics/numerical methods and translational research. He was a White House Presidential Leadership Scholar finalist and executive board member of multiple professional medical societies. Prior to SafeBeat Rx, he built a private practice clinic centered on a fully integrated remote monitoring platform he developed to facilitate care during the COVID-19 pandemic.

Rachita
Rachita Navara, MD.
Founder and CEO

Dr. Navara is a bioengineer and cardiologist specializing in heart rhythm disorders. She has been internationally recognized for her atrial fibrillation research, and she has led numerous award-winning medical innovation teams within academia (Stanford, UCSF, Wash U, MIT, Olin College of Engineering, UT Southwestern) and industry (Boston Scientific, Preserve, Harvard Brigham and Women’s Hospital). She is an appointed member of the National ACC Heart Rhythm Leadership Council and is HRS delegate to the AMA, directly shaping arrhythmia treatment guidelines. 

Kunj Patel, MD, MSc.
President, Founder, and CTO

Dr. Patel is a physical medicine and interventional pain physician from Harvard, Emory, Wash U, and NJIT with masters-level expertise in applied mathematics/numerical methods and translational research. He was a White House Presidential Leadership Scholar finalist and executive board member of multiple professional medical societies. Prior to SafeBeat Rx, he built a private practice clinic centered on a fully integrated remote monitoring platform he developed to facilitate care during the COVID-19 pandemic.

John Higgins, BSc.
Director of Engineering

Mr. Higgins brings 13 years’ experience in software engineering and artificial intelligence platforms, including managing the entire end-to-end software development lifecycle. As Founding Engineering Director for a Non-Profit R&D lab in Silicon Valley and Product Innovation Manager at Athenahealth, he brought countless products to end-users including executing a 150,000+ user, cloud SaaS environment interfacing with 29,000 healthcare providers.

Alejandro Alvarez, MSc.
Founding and Lead Engineer

Mr. Alvarez is a Senior Full-stack and Machine learning Software Engineer who has over ten years of experience, including at Fortune 500 companies, like Morgan Stanley, where he worked as a Senior Software engineer. He has a background in signal processing and telecommunication, and previously helped scale Wise.com through to a successful IPO as part of their debit card and machine learning engineering teams.

Ben Sackett, MSc.
Head of Operations & Technical Lead

Mr. Sackett, is SafeBeat’s Head of Operations and Technical Operations Lead, and he is a former senior engineer at Genentech, where he worked for 8 years and previously managed top software development teams. He also brings a wealth of knowledge from the pharmaceutical industry regarding clinical trials and commercialization, having helped with the rollout of novel products to millions of people around the globe. He leads SafeBeat’s early partnerships and growth strategies.

Rania deLeon, BSc.
Regulatory Affairs Manager

Rania deLeon is a biomedical engineer who brings seven years of experience in the medical device industry in both quality assurance and regulatory affairs, specifically in the area of cardiac electrophysiology. In her career, she has gotten medical device approvals from the FDA, Health Canada, European Union, and Australia, and has built electronic quality management systems from the ground up. Her approved devices are being used by thousands of cardiologists across the world today.

CEO Dr. Navara is the face of atrial fibrillation awareness for the American College of Cardiology

News

SafeBeat Rx

MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced the 50 companies selected to participate in the organization’s flagship four-month Accelerator

SafeBeat Rx CEO, Dr. Rachita Navara, recognized for AI Leadership & Entrepreneurship Awards by VentureBeat

Since 2019, VentureBeat has been honoring the women leaders, mentors, researchers and entrepreneurs who are transforming the AI industry

The Pulse Celebrates SafeBeat Rx CEO, Dr. Rachita Navara

Rachita Navara, CEO and cofounder of Safebeat RX, received a first funding of $120K. SafeBeat Rx replaces a hospitalization with a take-home kit that combines FDA-approved wearables with life-saving

Add Your Heading Text Here

Get in touch

    Get in touch